Compile Data Set for Download or QSAR
maximum 50k data
Found 26 of ic50 data for polymerid = 5932,50000574
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM159790(US9040501, 876400)
Affinity DataIC50:  101nMpH: 7.4Assay Description:The cytidine deaminase (CDA) enzymatic assay described by Cacciamani, T. et al., Arch. Biochem. Biophys. 1991, 290, 285-92; Cohen R. et al., J. Biol....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50421666(CHEMBL2311128 | US9040501, 876404)
Affinity DataIC50:  113nMpH: 7.4Assay Description:The cytidine deaminase (CDA) enzymatic assay described by Cacciamani, T. et al., Arch. Biochem. Biophys. 1991, 290, 285-92; Cohen R. et al., J. Biol....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM159792(US9040501, 878895)
Affinity DataIC50:  140nMpH: 7.4Assay Description:The cytidine deaminase (CDA) enzymatic assay described by Cacciamani, T. et al., Arch. Biochem. Biophys. 1991, 290, 285-92; Cohen R. et al., J. Biol....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007030(CHEMBL3237548)
Affinity DataIC50:  200nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111578(US8618075, 2a)
Affinity DataIC50:  200nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM159789(US9040501, 876437)
Affinity DataIC50:  237nMpH: 7.4Assay Description:The cytidine deaminase (CDA) enzymatic assay described by Cacciamani, T. et al., Arch. Biochem. Biophys. 1991, 290, 285-92; Cohen R. et al., J. Biol....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007025(TETRAHYDROURIDINE)
Affinity DataIC50:  340nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007029(CHEMBL3237547)
Affinity DataIC50:  400nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111577(US8618075, 1a)
Affinity DataIC50:  400nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111579(US8618075, 1)
Affinity DataIC50:  400nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007031(CHEMBL3237549)
Affinity DataIC50:  400nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111585(US8618075, 3a)
Affinity DataIC50:  400nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM159791(US9040501, 878519)
Affinity DataIC50:  1.62E+3nMpH: 7.4Assay Description:The cytidine deaminase (CDA) enzymatic assay described by Cacciamani, T. et al., Arch. Biochem. Biophys. 1991, 290, 285-92; Cohen R. et al., J. Biol....More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111581(US8618075, 2)
Affinity DataIC50:  2.00E+3nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111582(US8618075, 3)
Affinity DataIC50:  2.00E+3nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007033(CHEMBL3237551)
Affinity DataIC50:  4.00E+3nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111580(US8618075, 3b)
Affinity DataIC50:  4.00E+3nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111584(US8618075, 2b)
Affinity DataIC50:  5.00E+3nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM111583(US8618075, 1b)
Affinity DataIC50:  5.00E+3nMpH: 7.4Assay Description:The procedure to determine CDA enzymatic activity is based on published methodologies (for example, Cacciamani, T. et al., Arch. Biochem. Biophys. 19...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007034(CHEMBL3237552)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007032(CHEMBL3237550)
Affinity DataIC50:  5.00E+3nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007028(CHEMBL3237546)
Affinity DataIC50:  1.30E+4nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007026(CHEMBL3237544)
Affinity DataIC50:  2.00E+4nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007027(CHEMBL3237545)
Affinity DataIC50:  7.70E+4nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007035(CHEMBL3237553)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCytidine deaminase(Homo sapiens (Human))
Otsuka Pharmaceutical

US Patent
LigandPNGBDBM50007036(CHEMBL3237554)
Affinity DataIC50: >1.00E+5nMAssay Description:Inhibition of human recombinant cytidine deaminase assessed as cytidine to uridine formationMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed